Senores Pharmaceuticals Limited has informed the Exchange about Copy of Newspaper Publication for Audited Standalone and Consolidated financial results for quarter and financial year ended March 31, 2025
SENORES · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Senores Pharmaceuticals has informed BSE and NSE that it has published the extracts of its audited standalone and consolidated financial results for the quarter and full financial year ended March 31, 2025 in Financial Express (English and Gujarati editions) on May 16, 2025. This is a routine regulatory compliance filing under SEBI LODR Regulations 2015 (Regulations 30 and 47), requiring listed companies to publish their quarterly/annual results in newspapers. The full detailed financial results were separately filed with the stock exchanges under Regulation 33. The company has also uploaded the newspaper clippings on its website at www.senorespharma.com. Signed by Company Secretary Vinay Kumar Mishra.
This is a procedural compliance filing and not a new business development. Investors should refer to the separately filed detailed audited results (under Reg. 33) on BSE/NSE websites for actual numbers such as revenue, profit after tax, and EPS for Q4 and FY25.